We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Mettler-Toledo International
MTD
$28.8B
| $631K | 0.07% |
520
+307
| +144% | +$332K |
|
377
Shopify
SHOP
$160B
| $629K | 0.07% |
8,072
-15,537
| -66% | -$992K |
|
378
Textron
TXT
$15.3B
| $629K | 0.07% |
+7,816
| New | +$606K |
|
379
Open Text
OTEX
$6.41B
| $622K | 0.07% |
+14,797
| New | +$555K |
|
380
RELX
RELX
$64.2B
| $620K | 0.07% |
+15,645
| New | +$576K |
|
381
Hasbro
HAS
$12.9B
| $615K | 0.07% |
+12,036
| New | +$608K |
|
382
RingCentral
RNG
$5.09B
| $607K | 0.07% |
+17,884
| New | +$534K |
|
383
Brown & Brown
BRO
$23.8B
| $605K | 0.07% |
8,514
+3,091
| +57% | +$221K |
|
384
Mine Safety
MSA
$7.45B
| $602K | 0.07% |
3,563
+2,036
| +133% | +$331K |
|
385
AerCap
AER
$24.4B
| $596K | 0.07% |
8,022
-5,599
| -41% | -$370K |
|
386
Blue Owl Capital
OWL
$7.82B
| $594K | 0.07% |
+39,872
| New | +$536K |
|
387
Aptiv
APTV
$10.1B
| $594K | 0.07% |
6,616
+2,833
| +75% | +$244K |
|
388
Manhattan Associates
MANH
$11B
| $593K | 0.07% |
2,756
-3,652
| -57% | -$773K |
|
|
CMA
389
DELISTED
Comerica
CMA
| $590K | 0.07% |
+10,572
| New | +$478K |
|
390
Ericsson
ERIC
$33.7B
| $584K | 0.07% |
+92,646
| New | +$470K |
|
391
Commault Systems
CVLT
$5.47B
| $583K | 0.07% |
+7,297
| New | +$522K |
|
392
Celanese
CE
$4.96B
| $576K | 0.07% |
+3,705
| New | +$483K |
|
393
Sarepta Therapeutics
SRPT
$1.73B
| $574K | 0.07% |
+5,949
| New | +$571K |
|
394
Kymera Therapeutics
KYMR
$8.59B
| $571K | 0.07% |
+22,416
| New | +$401K |
|
395
Eversource Energy
ES
$27.3B
| $567K | 0.07% |
+9,186
| New | +$530K |
|
|
VSTO
396
DELISTED
Vista Outdoor Inc.
VSTO
| $565K | 0.07% |
+19,098
| New | +$525K |
|
397
SharkNinja
SN
$23.8B
| $564K | 0.07% |
+11,019
| New | +$504K |
|
398
Kosmos Energy
KOS
$1.44B
| $563K | 0.07% |
+83,934
| New | +$587K |
|
399
Biohaven
BHVN
$2.07B
| $561K | 0.06% |
+13,110
| New | +$408K |
|
|
400
Vertex Pharmaceuticals
VRTX
$121B
| $560K | 0.06% |
1,376
-32,168
| -96% | -$11.9M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.